HHS Secretary Alex Azar has a demand for the pharmaceutical industry: “Prices must start coming down.”

Drug prices are going up not just because of new innovations in medications, as the pharma industry frequently cites, but also because the industry is pricing existing products higher, according to a Health Affairs study.

Medical marketing in the United States reached $29.9 billion in 2016, up from $17.7 billion in 1997, according to a new analysis published in JAMA.

With high demand and high salaries, healthcare jobs took 44 spots of the 100 best jobs for 2019, as ranked by U.S. News.

The former CEO of health insurance provider Anthem, Joseph Swedish, has started a private equity firm as a co-founder, Axios reported.

More than 75 percent of healthcare executive leaders said their organization is increasing the pace of investment in big data and AI, with a majority citing fear of disruption by competitors, according to a survey by NewVantage Partners.

President Trump summoned top officials for a meeting at the White House on Jan. 8, Politico reported. The meeting comes as major drugmakers raised prices at the start of the year, prompting a Twitter response from the president.

Lark’s clinically validated AI coaching programs provide new ways for 23andMe customers to take action on their genetic information

An AI-driven approach for detecting an early sign of diabetic retinopathy achieved an accuracy rate of more than 98 percent, according to a study published in Computers in Biology and Medicine. The results could mean a quicker and cheaper solution for diagnosing the disease earlier and possibly prevent loss of eyesight.

Deaths from cancer in the United States declined 27 percent from a peak in 1991, according to the American Cancer Society.